Serum fetuin-A as a biomarker for gestational diabetes mellitus:  A meta-analysis

Nakshine VS, Jogdand SD. A comprehensive review of gestational diabetes mellitus: impacts on maternal health, fetal development, childhood outcomes, and long-term treatment strategies. Cureus. 2023;15(10):e47500.

PubMed  PubMed Central  Google Scholar 

Yong HY, MohdShariff Z, MohdYusof BN, Rejali Z, Tee YYS, Bindels J, et al. Independent and combined effects of age, body mass index and gestational weight gain on the risk of gestational diabetes mellitus. Sci Rep. 2020;10(1):8486.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trivett C, Lees ZJ, Freeman DJ. Adipose tissue function in healthy pregnancy, gestational diabetes mellitus and pre-eclampsia. Eur J Clin Nutri. 2021;75(12):1745–56.

Article  Google Scholar 

Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2020;29(10):1607.

Article  Google Scholar 

Sheiner E. Gestational diabetes mellitus: long-term consequences for the mother and child grand challenge: how to move on towards secondary prevention? Front Clin Diab Healthcare. 2020;1:546256.

Article  Google Scholar 

Reddi Rani P, Begum J. Screening and diagnosis of gestational diabetes mellitus, where do we stand. J Clin Diagn Res. 2016;10(4):QE01.

PubMed  Google Scholar 

Bourebaba L, Marycz K. Pathophysiological implication of fetuin-A glycoprotein in the development of metabolic disorders: a concise review. J Clin Med. 2019;8(12):2033.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chekol Abebe E, Tilahun Muche Z, Behaile T/Mariam A, Mengie Ayele T, Mekonnen Agidew M, Teshome Azezew M, et al. The structure, biosynthesis, and biological roles of fetuin-A: a review. Front Cell Dev Biol. 2022;10:945287.

Fu J, Retnakaran R. The life course perspective of gestational diabetes: an opportunity for the prevention of diabetes and heart disease in women. EClinicalMedicine. 2022;1:45.

Google Scholar 

Pan X, Wen SW, Bestman PL, Kaminga AC, Acheampong K, Liu A. Fetuin-A in metabolic syndrome: a systematic review and meta-analysis. PLoS ONE. 2020;15(3):e0229776.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trepanowski JF, Mey J, Varady KA. Fetuin-A: a novel link between obesity and related complications. Int J Obes (Lond). 2015;39(5):734–41.

Article  CAS  PubMed  Google Scholar 

Farhan S, Handisurya A, Todoric J, Tura A, Pacini G, Wagner O, et al. Fetuin-A characteristics during and after pregnancy: result from a case control pilot study. Int J Endocrinol. 2012;2012.

Kansu-Celik H, Ozgu-Erdinc AS, Kisa B, Findik RB, Yilmaz C, Tasci Y. Prediction of gestational diabetes mellitus in the first trimester: comparison of maternal fetuin-A, N-terminal proatrial natriuretic peptide, high-sensitivity C-reactive protein, and fasting glucose levels. Arch Endocrinol Metab. 2019;63(2):121–7.

PubMed  PubMed Central  Google Scholar 

Yakout SM, Hussein S, Al-Attas OS, Hussain SD, Saadawy M, Al-Daghri NM. Hepatokines fetuin A and fetuin B status in women with/without gestational diabetes mellitus [Internet]. Am J Transl Res. 2023;15.

Kralisch S, Hoffmann A, Lössner U, Kratzsch J, Blüher M, Stumvoll M, et al. Regulation of the novel adipokines/ hepatokines fetuin A and fetuin B in gestational diabetes mellitus. Metabolism. 2017;1(68):88–94.

Article  Google Scholar 

Wang Y, Koh WP, Jensen MK, Yuan JM, Pan A. Plasma fetuin-A levels and risk of type 2 diabetes mellitus in a Chinese population: a nested case-control study. Diabetes Metab J. 2019;43(4):474–86.

Article  PubMed  PubMed Central  Google Scholar 

Šimják P, Cinkajzlová A, Anderlová K, Kloučková J, Kratochvílová H, Lacinová Z, et al. Changes in Plasma concentrations and mRNA expression of hepatokines fetuin A, fetuin B and FGF21 in physiological pregnancy and gestational diabetes mellitus. Physiol Res. 2018;67:S531–42.

Article  PubMed  Google Scholar 

Lu D, Yang M, Yao Y, Xie Y. A clinical research study on the respective relationships between visfatin and human fetuin A and pregnancy outcomes in gestational diabetes mellitus. Taiwan J Obstet Gynecol. 2019;58(6):808–13.

Article  PubMed  Google Scholar 

Zbucka-Kretowska M, Kuzmicki M, Telejko B, Goscik J, Ciborowski M, Lipinska D, et al. First-trimester irisin and fetuin-a concentration in predicting macrosomia. J Maternal-Fetal Neonatal Med. 2019;32(17):2868–73.

Article  CAS  Google Scholar 

Al-Said NH, Taha FM, Abdel-Aziz GM, Abdel-Tawab MS. Fetuin-A level in type 2 diabetic patients: relation to microvascular complications. Egypt J Intern Med. 2018;30(3):121–30.

Article  Google Scholar 

Karamfilova V, Nedeva I, Gatev T, Gateva A, Assyov Y, Gerganova A, et al. Relationship of serum fetuin-A with metabolic and vascular parameters in patients with prediabetes and type 2 diabetes mellitus. Pharmacia. 2023;70(4):1455–61.

Article  CAS  Google Scholar 

Wang WJ, Zhang L, Zheng T, Zhang GH, Du K, Yang MN, et al. Fetuin-A and fetal growth in gestational diabetes mellitus. BMJ Open Diabetes Res Care. 2020;8(1).

Asghar A, Alam A, Fatima F. AHSG rs4918 Polymorphism poses a weak predisposition to insulin resistance during pregnancy. Pakistan J Med Assoc. 2018;68(5):698–701.

Google Scholar 

Rottenkolber M, Ferrari U, Holland L, Aertsen S, Kammer NN, Hetterich H, et al. The diabetes risk phenotype of young women with recent gestational diabetes. J Clin Endocrinol Metab. 2015;100(6):E910–8.

Article  CAS  PubMed  Google Scholar 

Iyidir OT, Degertekin CK, Yilmaz BA, Altinova AE, Toruner FB, Bozkurt N, et al. Serum levels of fetuin A are increased in women with gestational diabetes mellitus. Arch Gynecol Obstet. 2015;291(4):933–7.

Article  CAS  PubMed  Google Scholar 

Comments (0)

No login
gif